Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals why pigs don’t get sick from COVID-19
Pig cells undergo apoptosis - or controlled cell death - in response to infection with COVID-19.
Findings could lead to new treatments for human patients.

A new study shedding light on why pigs don’t get sick with COVID-19 could lead to better treatments in humans, according to new research.

Since the beginning of the pandemic, research into pigs has revealed that the animals do not display clinical signs of the disease, nor do they transmit the virus to other animals.

To find out why this was happening, researchers at IOWA State University introduced the virus to cultured porcine and human respiratory epithelial cells that line the respiratory tract. 

They found the pig cells underwent apoptosis - or controlled cell death - in response to infection at a higher rate than human epithelial cells. The findings are published in the journal Cell Death Discovery.

Study author Rahul Nelli, a research assistant professor of veterinary diagnostic and production animal medicine, said: “When we looked under the microscope, there was an interesting phenomenon going on inside the cells. The nuclei of the infected pig cells were starting to shred into fragments but not uninfected pig cells.” 

Shredding of the nucleus is a sign of apoptosis, which could be significant in helping pigs to avoid symptoms after exposure to SARS-CoV-2. If triggered early in the infection, apoptosis causes very little tissue damage and confines viral infection, thereby mitigating the risk of severe illness.

While human cells can also undergo apoptosis in response to coronavirus infection, the researchers found they do so much less often than pig cells. According to the study, porcine cells are around 100 times more likely to undergo apoptosis than human cells.

Human cells are more prone to succumb to necrosis, a less regulated form of cell death than apoptosis. The contents of a cell escape into the surrounding space during necrosis, triggering a strong hyperimmune response not seen during apoptosis. 

The study concludes that a wide-scale apoptosis response helps avoid disease because it disposes of infected cells quickly without the immune system overreacting. Conversely, wide-scale necrosis and the resulting hyperimmune response is less favourable to host cells. 

Co-author Luis Gimenez-Lirola, an associate professor of veterinary diagnostic and production animal medicine, commented: “We don’t want to over-conclude, but this response is probably something intrinsic to the pig immune system that is innate and not acquired. The idea is to kill the virus subtly but fast enough, so there’s not an excessive immune response triggered.” 

The team hopes that further study could pave the way to therapies to trigger apoptosis in human cells, helping those infected with COVID- to avoid severe symptoms.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.